Skip to main content
. Author manuscript; available in PMC: 2020 Mar 1.
Published in final edited form as: J Rheumatol. 2018 Nov 15;46(3):237–244. doi: 10.3899/jrheum.180071

Figure 3.

Figure 3

Patterns of Adding or Switching Biologics or JAKi*, According to MBDA Score (N=60,596)

JAKi : Janus kinase inhibitor; MBDA: Multi-biomarker disease activity.

* addition or switching between day 4 and 183 after the MBDA test